|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kosary CL: FIGO stage, histology,
histologic grade, age and race as prognostic factors in determining
survival for cancers of the female gynecological system: An
analysis of 1973-87 SEER cases of cancers of the endometrium,
cervix, ovary, vulva, and vagina. Semin Surg Oncol. 10:31–46. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yeung KT and Yang J:
Epithelial-mesenchymal transition in tumor metastasis. Mol Oncol.
11:28–39. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nieto MA: Epithelial plasticity: A common
theme in embryonic and cancer cells. Science. 342:12348502013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sánchez-Tilló E, Fanlo L, Siles L,
Montes-Moreno S, Moros A, Chiva-Blanch G, Estruch R, Martinez A,
Colomer D, Győrffy B, et al: The EMT activator ZEB1 promotes tumor
growth and determines differential response to chemotherapy in
mantle cell lymphoma. Cell Death Differ. 21:247–257. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pinho AV, Rooman I and Real FX:
p53-dependent regulation of growth, epithelial-mesenchymal
transition and stemness in normal pancreatic epithelial cells. Cell
Cycle. 10:1312–1321. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kahn RA and Lambright DG: A PH domain with
dual phospholipid binding sites regulates the ARF GAP, ASAP1.
Structure. 23:1971–1973. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Müller T, Stein U, Poletti A, Garzia L,
Rothley M, Plaumann D, Thiele W, Bauer M, Galasso A, Schlag P, et
al: ASAP1 promotes tumor cell motility and invasiveness, stimulates
metastasis formation in vivo and correlates with poor survival in
colorectal cancer patients. Oncogene. 29:2393–2403. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sato H, Hatanaka KC, Hatanaka Y,
Hatakeyama H, Hashimoto A, Matsuno Y, Fukuda S and Sabe H: High
level expression of AMAP1 protein correlates with poor prognosis
and survival after surgery of head and neck squamous cell carcinoma
patients. Cell Commun Signal. 12:172014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hashimoto S, Hirose M, Hashimoto A,
Morishige M, Yamada A, Hosaka H, Akagi K, Ogawa E, Oneyama C,
Agatsuma T, et al: Targeting AMAP1 and cortactin binding bearing an
atypical src homology 3/proline interface for prevention of breast
cancer invasion and metastasis. Proc Natl Acad Sci USA. 103:pp.
7036–7041. 2006; View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hou T, Yang C, Tong C, Zhang H, Xiao J and
Li J: Overexpression of ASAP1 is associated with poor prognosis in
epithelial ovarian cancer. Int J Clin Exp Pathol. 7:280–287.
2013.PubMed/NCBI
|
|
13
|
Yue J, Sheng Y, Ren A and Penmatsa S: A
miR-21 hairpin structure-based gene knockdown vector. Biochem
Biophys Res Commun. 394:667–672. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Guo X, Zhang R, Wang J and Lu R: Antiviral
RNA silencing initiated in the absence of RDE-4, a double-stranded
RNA binding protein, in Caenorhabditis elegans. J Virol.
87:10721–10729. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ehlers JP, Worley L, Onken MD and Harbour
JW: DDEF1 is located in an amplified region of chromosome 8q and is
overexpressed in uveal melanoma. Clin Cancer Res. 11:3609–3613.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang L, Moss T, Mangala LS, Marini J, Zhao
H, Wahlig S, Armaiz-Pena G, Jiang D, Achreja A, Win J, et al:
Metabolic shifts toward glutamine regulate tumor growth, invasion
and bioenergetics in ovarian cancer. Mol Syst Biol. 10:7282014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kinoshita R, Nam JM, Ito YM, Hatanaka KC,
Hashimoto A, Handa H, Otsuka Y, Hashimoto S, Onodera Y, Hosoda M,
et al: Co-overexpression of GEP100 and AMAP1 proteins correlates
with rapid local recurrence after breast conservative therapy. PLoS
One. 8:e767912013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Handa H, Hashimoto A, Hashimoto S and Sabe
H: Arf6 and its ZEB1-EPB41L5 mesenchymal axis are required for both
mesenchymal- and amoeboid-type invasion of cancer cells. Small
GTPases. 1–7. 2016.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhao G, Guo Y, Chen Z, Wang Y, Yang C,
Dudas A, Du Z, Liu W, Zou Y, Szabo E, et al: miR-203 functions as a
tumor suppressor by inhibiting epithelial to mesenchymal transition
in ovarian cancer. J Cancer Sci Ther. 7:34–43. 2015.PubMed/NCBI
|
|
20
|
Viticchiè G, Lena AM, Latina A, Formosa A,
Gregersen LH, Lund AH, Bernardini S, Mauriello A, Miano R, Spagnoli
LG, et al: MiR-203 controls proliferation, migration and invasive
potential of prostate cancer cell lines. Cell Cycle. 10:1121–1131.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lin D, Watahiki A, Bayani J, Zhang F, Liu
L, Ling V, Sadar MD, English J, Fazli L, So A, et al: ASAP1, a gene
at 8q24, is associated with prostate cancer metastasis. Cancer Res.
68:4352–4359. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Alvero AB, Montagna MK and Mor G:
Correlation of caspase activity and in vitro chemo-response in
epithelial ovarian cancer cell lines. Methods Mol Biol. 414:79–82.
2008.PubMed/NCBI
|
